GU Research Network — Omaha, Nebraska

GU Research Network is a clinical research site located in Omaha, Nebraska, United States 68130.

Crixeo Health Trust Score: 80/100 (GOOD). This profile has not yet been claimed by the site owner.

GU Research Network has participated in 16 clinical trials with 3 currently active.

Therapeutic areas: Metastatic Castration Resistant Prostate Cancer (mCRPC), Metastatic Prostate Cancer, UC (Urothelial Cancer).

Sponsors: Constellation Pharmaceuticals, Dendreon, Incyte Corporation.

Sponsor Feasibility Report

Trust Score: 80/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for GU Research Network?

GU Research Network has a Crixeo Trust Score of 80/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has GU Research Network conducted?

GU Research Network has 16 clinical trials on record, with 3 currently active. Their work covers Metastatic Castration Resistant Prostate Cancer (mCRPC), Metastatic Prostate Cancer, UC (Urothelial Cancer).

Is GU Research Network accredited by Crixeo Health?

GU Research Network has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about GU Research Network?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.